Key data from Boehringer Ingelheim’s hepatitis C virus (HCV) clinical trial programme, HCVerso, focusing on interferon-free treatment, has been selected for inclusion in the official European Association for the Study of the Liver (EASL) press office activities.
No Comments »
Filed under: Pharmacy News
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
No Comments »
Filed under: Pharmacy News
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
No Comments »
Filed under: Pharmacy News
Testing rates for hepatitis C virus (HCV) infection in the United States remain low; testing occurs most often in people outside of high-risk groups, new research hints. Medscape Medical News
No Comments »
Filed under: General Health News
Pennsylvania reports an increasing incidence of hepatitis C in younger people, in line with observations from other states. Medscape Medical News
No Comments »
Filed under: General Health News
(MedPage Today) — Broader screening for hepatitis C would be cost-effective but would not by itself markedly reduce morbidity and mortality from the virus, researchers reported.
No Comments »
Filed under: General Health News
MedivirAB a research based specialty pharmaceutical company focused on infectious diseases announces that its oral, once daily investigational protease inhibitor TMC435, developed by Janssen Pharmaceuticals for the treatment of Hepatitis C virus (HCV), has commenced patient dosing and started screening in two new phase III clinical trials, HPC3001 and HPC3011, respectively.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — Statins may cause drug-drug interactions for patients taking drugs to treat HIV/AIDS or hepatitis C, according to a new statin warning from the FDA.
No Comments »
Filed under: General Health News
(MedPage Today) — More Americans now die from hepatitis C infection than from HIV, researchers from the Centers for Disease Control and Prevention reported.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A new drug for hepatitis C can reduce the effectiveness of some HIV medications if they are taken together and vice versa, the FDA is warning.
No Comments »
Filed under: General Health News
